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Background: Cerebral Palsy (CP) and other acquired neurological disorders result from brain 
lesions that alter motor function in children. The impact of these deficits can impair a child’s 
ability to use their upper extremity (UE) for normal daily activities such as eating and playing.  
Robotic-assisted therapy has been shown to improve motor function in children with CP. 
Training parameters such as intensity and frequency were initially based on findings from 
studies measuring change in adults following stroke. Based on this, high intensity (960 
repetitions per session) and increased frequency (2 times per week, 9 weeks) were initially 
implemented for children. Early findings demonstrated improvement in UE function for children 
with CP; however, training sessions were long, making them difficult to complete given the 
shorter attention span of the pediatric population. Determining the potential impact of a shorter, 
more optimal, dosage of robotic-assisted therapy for children would facilitate rehab training 
efficiency and maximize cost effectiveness.   
Purpose: The purpose of this study was to identify the impact on motor impairments and 
movement capacity with variances in treatment intensity (number of repetitions per session) 
while holding constant the frequency of the application (2 times per week, 9 weeks) for robotic-
assisted UE training for children with CP. 
Methods: Six children between the ages of 6 and 8 were analyzed from two separate studies 
evaluating the effectiveness of robotic-assisted training for UE functional improvement. The first 
study featured training at high intensity and frequency while the second study used lower 
intensity parameters but the same frequency. To be eligible for either study, children were 
required to have UE hemiplegia and the ability to participate in a task for up to 60 minutes. 
Twice weekly, each child participated in robotic training sessions consisting of either 960, 640, 
or 320 task-specific reaching movements of the affected UE.  Each child completed a total of 16 
robotic training sessions over a 9-week period as well as one pre- and one post-test session. 
Outcome measures included active range of motion (AROM), strength testing and tone using 
the Modified Ashworth Scale (MAS). The children’s motor capacity was evaluated using the 
adaptive Fugl-Meyer scale (FM).  
Results: Percent change scores were calculated for each participant for each outcome 
measurement. AROM results for the shoulder resulted in an average increase of 10.6% for 
flexion and a 13.3% increase for abduction in both the 320 and 640 groups. Shoulder external 
rotation increased by an average of 13.6% for all three groups. Arm strength increased an 
average of 12.3% for all three groups. The MAS had an average decrease in tone of 23.8% 
across all 3 groups. Scores on the FM increased an average of 23% with in-depth analysis 
revealing shoulder movement to be the primary area for motor capacity change at 96%. 
Conclusion: These findings indicate that lower intensities of robotic-assisted therapy (320 and 
640 repetitions) were as effective as the larger dose originally prescribed for children with CP. 
Outcome measures improved in all 3 groups and did not vary between dosing groups. This 
suggests that longer intensity sessions of robotic-assisted therapies may not be necessary to 
produce AROM, strength, and motor capacity changes. Further trials with more subjects are 
needed to validate these results.   
